نتایج جستجو برای: hepatocellular

تعداد نتایج: 54283  

Journal: :hepatitis monthly 0
ileana constantinescu immunology of transplantation discipline, faculty of medicine, carol davila university of medicine and pharmacy, bucharest, romania; center for immunogenetics and virology, fundeni clinical institute, bucharest, romania; centre for immunogenetics and virology, fundeni clinical institute, bucharest, romania. tel: +40-744341984, fax: +40-213180448 andrei-antoniu dinu center for immunogenetics and virology, fundeni clinical institute, bucharest, romania voicu boscaiu “gheorghe mihoc-caius iacob” institute of statistics and applied mathematics, bucharest, romania marius niculescu colentina clinical hospital, bucharest, romania

conclusions genotype d was the main genotype detected in romanian patients with chronic hbv infection. genotype d presented both bcp and pc mutations more frequently. results we detected two hbv genotypes; a (8.1%) and d (60.5%), and a mixture of genotypes a and d (31.4%) (p < 0.001). basal core promoter (bcp) a1762t/g1764a and precore (pc) g1896a mutations were detected in these romanian patie...

Journal: :hepatitis monthly 0
man ru bi the second clinical medical college, harbin medical university, harbin, china li ying zhu the fourth clinical medical college, harbin medical university, harbin, china bing zhu yan the second clinical medical college, harbin medical university, harbin, china li yan chen the second clinical medical college, harbin medical university, harbin, china fu xiang wang the fourth clinical medical college, harbin medical university, harbin, china ying ji ma the fourth clinical medical college, harbin medical university, harbin, china; the fourth clinical medical college, harbin medical university, harbin 150001, china. tel: +86-45182576842, fax: +86-45182576842

conclusions expression of hmgb1 and c-iap2 proteins was associated with hcc development and progression, and the expression of hmgb1 and c-iap2 proteins in hcc were significantly associated with each other. additionally, these proteins may show promise as biomarkers to predict hcc progression. background hepatocellular carcinoma (hcc) is one of the most important health problems in china. objec...

Journal: :گوارش 0
naser ebrahimi daryani hazher saberi mohammad reza pashaei mohammad taher samera shirzad

liver lesion is a common condition, which often detect incidentally. a large proportion of liver masses can be diagnosed by progression in imaging modalities. although, definite diagnosis of liver mass's nature can be made by biopsy of lesion and histopathologic examination, but with imaging findings, we can approach to the diagnosis. in this study, we review many valuable articles and scientif...

Journal: :hepatitis monthly 0
khalid a. alswat department of medicine, liver disease research center, king saud university, riyadh, saudi arabia; department of medicine, liver disease research center, king saud university, riyadh, saudi arabia. tel: +966-14679167, fax: +966-14671217 faisal m. sanai department of hepatobiliary science and liver transplantation, king abdulaziz medical city, national guard health affairs, riyadh, saudi arabia mansour altuwaijri department of medicine, liver disease research center, king saud university, riyadh, saudi arabia ali albenmousa department of gastroenterology, riyadh military hospital, riyadh, saudi arabia majid almadi department of medicine, liver disease research center, king saud university, riyadh, saudi arabia waleed k. al-hamoudi department of medicine, liver disease research center, king saud university, riyadh, saudi arabia

conclusions the data from this cohort indicates that most of patients diagnosed with hcc present at late tumor and liver disease stages, when prognosis is usually dismal. regular cancer surveillance in cirrhotic patients might change the outcomes. further studies with results of treatment outcomes in this community are needed. background hepatocellular carcinoma (hcc) is one of the leading caus...

Journal: :hepatitis monthly 0
shi jing department of clinical laboratory, the first affiliated hospital, chongqing medical university, chongqing, china shi jing department of clinical laboratory, the first affiliated hospital, chongqing medical university, chongqing, china guo bianqin key laboratory of clinical laboratory diagnostics, college of laboratory medicine, chongqing medical university, chongqing, china liu ping key laboratory of clinical laboratory diagnostics, college of laboratory medicine, chongqing medical university, chongqing, china liang qindong key laboratory of clinical laboratory diagnostics, college of laboratory medicine, chongqing medical university, chongqing, china liu chenggui key laboratory of clinical laboratory diagnostics, college of laboratory medicine, chongqing medical university, chongqing, china

conclusions the established method has an acceptable performance in quantifying yb-1. in addition, serum yb-1 may aid in the diagnosis of hcc. results the developed method was linear to 150 μg/l of yb-1 with a minimum detection limit of 0.01 μg/l. the average recoveries were between 93.9% and 109.0%. the mean intra- and inter-assay coefficients of variation (cvs) were 4.0-4.8% and 8.2-10.2%, re...

Journal: :hepatitis monthly 0
jamal sarvari institute for cancer research, shiraz university of medical sciences, shiraz, ir iran; department of bacteriology and virology, shiraz university of medical sciences, shiraz, ir iran; department of biochemistry and functional proteomics, yamaguchi university graduate school of medicine, yamaguchi, japan zahra mojtahedi institute for cancer research, shiraz university of medical sciences, shiraz, ir iran seyed ali reza taghavi department of internal medicine, shiraz university of medical sciences, shiraz, ir iran yasuhiro kuramitsu department of biochemistry and functional proteomics, yamaguchi university graduate school of medicine, yamaguchi, japan mahmoud shamsi shahrabadi department of virology, tehran university of medical sciences, tehran, ir iran abbas ghaderi institute for cancer research, shiraz university of medical sciences, shiraz, ir iran; institute for cancer research, shiraz university of medical sciences, shiraz, ir iran. tel: +98-7112303687, fax: +98-7112304952

conclusions cd5l might be a useful biomarker for early diagnosis of hcc in hcv cirrhotic patients. lrg and hp α2 isoforms could be potential markers for distinguishing viral hcc. our results also further support the presence of varying molecules involved in hepatocarcinogenesis in hbv when compared with hcv infection. patients and methods two-dimensional polyacrylamide gel electrophoresis combi...

Journal: :hepatitis monthly 0
seyed moayed alavian baqiyatallah research center for gastroenterology and liver diseases (brcgl), baqiyatallah university of medical sciences, tehran, ir iran; baqiyatallah research center for gastroenterology and liver diseases (brcgl), tehran hepatitis center, baqiyatallah university of medical sciences, p.o.box: 14155/ 3651, tehran, ir iran. tel/fax: +98- 2181264070 hossein haghbin baqiyatallah research center for gastroenterology and liver diseases (brcgl), baqiyatallah university of medical sciences, tehran, ir iran

conclusions hbv and hcv are important culprits of hcc in emro countries and the middle east and different nations need different strategies to tackle them accordingly. countries with high rates of hbv such as turkey should continue their hbv vaccination and also increase sanitation. nations with high hcv rates such as egypt should maintain their blood product monitoring in addition to increased...

Journal: :hepatitis monthly 0
enayatollah seydi department of pharmacology and toxicology, faculty of pharmacy, shahid beheshti university of medical sciences, tehran, ir iran abbasali motallebi research and education and extension organization (areeo) and iranian fisheries research organization, ministry of jihad-e-agriculture, tehran, ir iran maryam dastbaz department of pharmacology and toxicology, faculty of pharmacy, shahid beheshti university of medical sciences, tehran, ir iran sahar dehghan department of pharmacology and toxicology, faculty of pharmacy, shahid beheshti university of medical sciences, tehran, ir iran ahmad salimi department of pharmacology and toxicology, faculty of pharmacy, shahid beheshti university of medical sciences, tehran, ir iran; department of pharmacology and toxicology, school of pharmacy, ardabil university of medical sciences, ardabil, ir iran melika nazemi research and education and extension organization (areeo) and iranian fisheries research organization, ministry of jihad-e-agriculture, tehran, ir iran

conclusions our results suggest that h. parva and h. oculata may be promising therapeutic candidates for the treatment of hcc, following further confirmatory in vivo experiments and clinical trials. results our results showed that h. parva methanolic extracts (250, 500, and 1000 µg/ml) and h. oculata methanolic extracts (200, 400, and 800 µg/ml) increased reactive oxygen species (ros) formation...

Journal: :Liver International 2021

Molecular analysis of primary liver malignancies has provided a refinement the pathological diagnosis this entity and identification an increasing number tumor subtypes hepatocellular proliferation, either malignant (hepatocellular carcinomas) or benign adenomas). Besides diagnosis, combined pathomolecular approach can also provide further insights into patient prognosis, help select patients w...

Journal: :hepatitis monthly 0
ya wen viral hepatitis key laboratary, department of infectious disease, xiangya hospital, central south university; changsha, china yi xiang zheng viral hepatitis key laboratary, department of infectious disease, xiangya hospital, central south university; changsha, china de ming tan viral hepatitis key laboratary, department of infectious disease, xiangya hospital, central south university; changsha, china; viral hepatitis key laboratary, department of infectious disease, xiangya hospital, central south university, changsha, china. tel: +86-13958868582, fax: +86-073189753766

results patients who attained sustained virological response had a less risk (85%) for all-cause mortality and about 63% reduced risk of hepatocellular carcinoma incidence than those who did not achieve sustained virological response. based on deeply analysis, the stage of liver fibrosis was a risk factor at baseline for the incidence of hepatocellular carcinoma. conclusions sustained virologic...

نمودار تعداد نتایج جستجو در هر سال

با کلیک روی نمودار نتایج را به سال انتشار فیلتر کنید